Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
41.62
+0.02 (0.05%)
At close: Jan 23, 2026
SHA:603014 Revenue
Shandong Weigao Blood Purification Products had revenue of 971.37M CNY in the quarter ending September 30, 2025, with 23.86% growth. This brings the company's revenue in the last twelve months to 3.70B. In the year 2024, Shandong Weigao Blood Purification Products had annual revenue of 3.60B with 2.03% growth.
Revenue (ttm)
3.70B
Revenue Growth
+2.03%
P/S Ratio
4.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.60B | 71.87M | 2.03% |
| Dec 31, 2023 | 3.53B | 106.03M | 3.09% |
| Dec 31, 2022 | 3.43B | 515.59M | 17.71% |
| Dec 31, 2021 | 2.91B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition